文献速递心律失常心力衰竭与心肌病

致心律失常性右心室心肌病室性心律失常新预测模型

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
PubMed 文献 · Eur Heart J · 2022-01-01

研究开发了Cox回归预测模型,乐观校正C指数为0.77(95%CI 0.73-0.81),校准斜率为0.93(95%CI 0.92-0.95),决策曲线分析显示临床获益优于现行共识ICD植入算法,在相同保护比例下减少20.3%的ICD植入(P<0.001)。

要点

  • 模型纳入年龄、性别、近期晕厥、NSVT、PVC负荷、T波倒置导联数及右室射血分数预测ARVC患者室性心律失常风险。
  • 模型区分度良好,乐观校正C指数0.77(95%CI 0.73-0.81),校准斜率0.93(95%CI 0.92-0.95)。
  • 决策曲线分析显示模型临床获益优于现行共识ICD植入算法,可减少20.3%的ICD植入而不减少受保护患者。

核心结论

  • 利用易获得的临床参数构建的预测模型可估算ARVC患者室性心律失常年风险并指导一级预防ICD决策。

研究设计与样本

  • 随访4.83年(四分位距2.44-9.33年),采用Cox回归开发预测模型并进行内部验证。

主要发现

  • 随访期间146例(27.7%)发生持续性室性心律失常,定义为心脏性猝死、中止的心脏性猝死、持续性室性心动过速或适当的ICD治疗。
  • 预设的八个预测因子中除左室射血分数外均保留在最终模型。
  • 模型乐观校正C指数为0.77(95%CI 0.73-0.81),校准斜率为0.93(95%CI 0.92-0.95)。
  • 决策曲线分析显示模型临床获益优于现行共识ICD植入算法,在相同保护患者比例下减少20.3%的ICD植入(P<0.001)。

关键数值与推荐

  • 预测因子包括年龄、性别、近6个月内心源性晕厥、非持续性室性心动过速、24小时室性早搏数量、T波倒置导联数、右室射血分数和左室射血分数(左室射血分数未保留在最终模型)。
  • 模型在线计算器见于www.arvcrisk.com。

临床怎么用

  • 临床医生可使用该模型估算ARVC患者室性心律失常年风险,辅助一级预防ICD植入决策。
  • 模型预测的临床获益优于现行共识ICD植入算法,可在不减少受保护患者的前提下减少部分ICD植入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is characterized by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). We aimed to develop a model for individualized prediction of incident VA/SCD in ARVC patients. METHODS AND RESULTS: Five hundred and twenty-eight patients with a definite diagnosis and no history of sustained VAs/SCD at baseline, aged 38.2 ± 15.5 years, 44.7% male, were enrolled from five registries in North America and Europe. Over 4.83 (interquartile range 2.44-9.33) years of follow-up, 146 (27.7%) experienced sustained VA, defined as SCD, aborted SCD, sustained ventricular tachycardia, or appropriate implantable cardioverter-defibrillator (ICD) therapy. A prediction model estimating annual VA risk was developed using Cox regression with internal validation. Eight potential predictors were pre-specified: age, sex, cardiac syncope in the prior 6 months, non-sustained ventricular tachycardia, number of premature ventricular complexes in 24 h, number of leads with T-wave inversion, and right and left ventricular ejection fractions (LVEFs). All except LVEF were retained in the final model. The model accurately distinguished patients with and without events, with an optimism-corrected C-index of 0.77 [95% confidence interval (CI) 0.73-0.81] and minimal over-optimism [calibration slope of 0.93 (95% CI 0.92-0.95)]. By decision curve analysis, the clinical benefit of the model was superior to a current consensus-based ICD placement algorithm with a 20.3% reduction of ICD placements with the same proportion of protected patients (P < 0.001). CONCLUSION: Using the largest cohort of patients with ARVC and no prior VA, a prediction model using readily available clinical parameters was devised to estimate VA risk and guide decisions regarding primary prevention ICDs (www.arvcrisk.com).

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2022. PMID: 35441664. doi:10.1093/eurheartj/ehac180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。